• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高载脂蛋白B血症:持续性非卧床腹膜透析治疗的慢性肾衰竭患者的主要血脂蛋白异常血症。

Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.

作者信息

Sniderman A, Cianflone K, Kwiterovich P O, Hutchinson T, Barre P, Prichard S

出版信息

Atherosclerosis. 1987 Jun;65(3):257-64. doi: 10.1016/0021-9150(87)90041-4.

DOI:10.1016/0021-9150(87)90041-4
PMID:3619989
Abstract

In the present study, plasma cholesterol, triglyceride, low density lipoprotein (LDL)-cholesterol, high density lipoprotein (HDL)-cholesterol, and the major protein in LDL, apoB, were measured in 28 patients with chronic renal failure treated with hemodialysis and in 28 patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis (CAPD). Elevated plasma triglycerides and reduced HDL cholesterol were frequent in both the hemodialysis and CAPD patients. However LDL levels were significantly higher in the CAPD patients as evident both by LDL cholesterol and LDL apoB. Even so, only one of the CAPD patients was hypercholesterolemic whereas 14 (or 50%) had hyperapobetalipoproteinemia (HyperapoB). Insulin-dependent diabetes was more frequent in the CAPD group but only 2 of the 9 insulin-dependent diabetics in this group had HyperapoB, and therefore, diabetes mellitus cannot account for the difference between the 2 groups. Thus HyperapoB appears to be a prevalent dyslipoproteinemia in CAPD patients and as such might be another factor which places CAPD patients at particularly increased risk of atherosclerosis.

摘要

在本研究中,对28例接受血液透析治疗的慢性肾衰竭患者和28例接受持续性非卧床腹膜透析(CAPD)治疗的慢性肾衰竭患者的血浆胆固醇、甘油三酯、低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇以及LDL中的主要蛋白质载脂蛋白B进行了测量。血液透析患者和CAPD患者中均经常出现血浆甘油三酯升高和HDL胆固醇降低的情况。然而,无论是通过LDL胆固醇还是LDL载脂蛋白B来看,CAPD患者的LDL水平均显著更高。即便如此,CAPD患者中只有1例患有高胆固醇血症,而有14例(或50%)患有高载脂蛋白血症(HyperapoB)。CAPD组中胰岛素依赖型糖尿病更为常见,但该组9例胰岛素依赖型糖尿病患者中只有2例患有HyperapoB,因此,糖尿病不能解释两组之间的差异。由此可见,HyperapoB似乎是CAPD患者中普遍存在的一种脂蛋白异常血症,因此可能是使CAPD患者动脉粥样硬化风险特别增加的另一个因素。

相似文献

1
Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.高载脂蛋白B血症:持续性非卧床腹膜透析治疗的慢性肾衰竭患者的主要血脂蛋白异常血症。
Atherosclerosis. 1987 Jun;65(3):257-64. doi: 10.1016/0021-9150(87)90041-4.
2
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.肾衰竭中含载脂蛋白B的脂蛋白:与透析方式的关系。
Kidney Int. 1999 Apr;55(4):1536-42. doi: 10.1046/j.1523-1755.1999.00375.x.
3
Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis.接受透析治疗患者的脂质、脂蛋白和载脂蛋白异常
J Tongji Med Univ. 1997;17(2):126-8. doi: 10.1007/BF02888251.
4
Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels.持续性非卧床腹膜透析期间腹膜蛋白丢失的动力学:II. 脂蛋白渗漏及其对血浆脂质水平的影响。
Kidney Int. 1990 Mar;37(3):980-90. doi: 10.1038/ki.1990.74.
5
Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.接受持续性非卧床腹膜透析和血液透析患者的血脂参数,包括脂蛋白(a) 。
Perit Dial Int. 1995 Oct-Dec;15(8):342-7.
6
Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.终末期肾病中的血浆胆固醇代谢。血液透析或腹膜透析治疗的差异。
J Clin Invest. 1986 Apr;77(4):1071-83. doi: 10.1172/JCI112406.
7
Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.血液透析前、血液透析、持续性非卧床腹膜透析及移植后患者中Lp(a)及其他载脂蛋白的浓度。
Clin Chem Lab Med. 2000 May;38(5):421-5. doi: 10.1515/CCLM.2000.061.
8
Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.残余肾功能影响持续非卧床腹膜透析患者的血脂谱。
Perit Dial Int. 1997 May-Jun;17(3):243-9.
9
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.低白蛋白血症和脂蛋白脂肪酶在持续性非卧床腹膜透析患者高脂血症中的作用
Metabolism. 1991 Oct;40(10):1002-8. doi: 10.1016/0026-0495(91)90120-l.
10
Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.持续非卧床腹膜透析患者血浆脂蛋白(a)升高与蛋白质和葡萄糖的腹膜转运有关。
Nephron. 1996;72(2):135-44. doi: 10.1159/000188831.

引用本文的文献

1
Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients.随机对照试验研究葡萄糖保存型腹膜透析在糖尿病患者中的应用。
J Am Soc Nephrol. 2013 Nov;24(11):1889-900. doi: 10.1681/ASN.2012100987. Epub 2013 Aug 15.
2
Cardiovascular risk in the peritoneal dialysis patient.腹膜透析患者的心血管风险。
Nat Rev Nephrol. 2010 Aug;6(8):451-60. doi: 10.1038/nrneph.2010.68. Epub 2010 Jun 22.